Ob­sE­va makes cuts to lead­er­ship team, board of di­rec­tors in an­oth­er at­tempt to stay afloat

Women’s health biotech Ob­sE­va is down­siz­ing its US-based ex­ec­u­tive team and board of di­rec­tors, the com­pa­ny an­nounced Fri­day, the lat­est in a se­ries of aus­ter­i­ty mea­sures.

Bri­an O’Callaghan stepped down as CEO on Feb. 23. The chief com­mer­cial of­fi­cer, chief clin­i­cal of­fi­cer and chief trans­for­ma­tion of­fi­cer al­so left Ob­sE­va on Thurs­day. The cur­rent CFO, Will Brown, will take on a sec­ond role as in­ter­im CEO while the com­pa­ny search­es for a per­ma­nent leader.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER